These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16094337)

  • 1. Singapore: an irresistible force.
    Cyranoski D
    Nature; 2005 Aug; 436(7052):767-8. PubMed ID: 16094337
    [No Abstract]   [Full Text] [Related]  

  • 2. The antibiotic pipeline--challenges, costs, and values.
    Wenzel RP
    N Engl J Med; 2004 Aug; 351(6):523-6. PubMed ID: 15295041
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 4. Recruiters and industry.
    Jackson M
    Nature; 2004 Mar; 428(6981):450. PubMed ID: 15042100
    [No Abstract]   [Full Text] [Related]  

  • 5. Gaining medical momentum.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):19-23. PubMed ID: 15175707
    [No Abstract]   [Full Text] [Related]  

  • 6. The new Silk Road.
    Chien K; Chien L
    Nature; 2004 Mar; 428(6979):208-9. PubMed ID: 15014508
    [No Abstract]   [Full Text] [Related]  

  • 7. High road to Scotland.
    Smaglik P
    Nature; 2004 Nov; 432(7013):128-9. PubMed ID: 15525995
    [No Abstract]   [Full Text] [Related]  

  • 8. Great expectations--SID and industry relationship: a 20-year perspective.
    Shroot B
    J Invest Dermatol; 2007 Jul; 127(7):1561-2. PubMed ID: 17568792
    [No Abstract]   [Full Text] [Related]  

  • 9. An eastern promise of regeneration.
    Caruana C
    Nature; 2005 Jun; 435(7044):998-9. PubMed ID: 15959526
    [No Abstract]   [Full Text] [Related]  

  • 10. [Patentability of an antibody: evolution of rules and practices and prospects].
    Collin M; Davison S
    Med Sci (Paris); 2019 Dec; 35(12):1175-1181. PubMed ID: 31903934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Description of the French players from Avenir's investment program: the role of MabDesign].
    Groux N; Pontremoli R; Vuddamalay G; Richard G; Pons D
    Med Sci (Paris); 2019 Dec; 35(12):1198-1201. PubMed ID: 31903939
    [No Abstract]   [Full Text] [Related]  

  • 12. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 13. Timeline of events: A brief history of what made news this year.
    Nat Med; 2012 Dec; 18(12):1728. PubMed ID: 23223051
    [No Abstract]   [Full Text] [Related]  

  • 14. Merck opts for shake-up to clear drug pipeline.
    Nature; 2005 Dec; 438(7071):1076-7. PubMed ID: 16371975
    [No Abstract]   [Full Text] [Related]  

  • 15. An audience with...Gloria Maldonado.
    Maldonado G; Mullard A
    Nat Rev Drug Discov; 2015 Sep; 14(9):596. PubMed ID: 26279177
    [No Abstract]   [Full Text] [Related]  

  • 16. Defining innovation.
    Hughes B
    Nat Rev Drug Discov; 2009 Sep; 8(9):683-4. PubMed ID: 19721435
    [No Abstract]   [Full Text] [Related]  

  • 17. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 18. Aligning pharmaceutical innovation with medical need.
    Nathan C
    Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
    [No Abstract]   [Full Text] [Related]  

  • 19. Market watch: Therapeutic area 'heat map' for emerging markets.
    Gautam A; Li L; Srinivasan K
    Nat Rev Drug Discov; 2015 Aug; 14(8):518-9. PubMed ID: 26160486
    [No Abstract]   [Full Text] [Related]  

  • 20. Singapore pulls plug on US collaboration.
    Fuyuno I
    Nature; 2006 Aug; 442(7102):493. PubMed ID: 16885950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.